China Universal Asset Management Co. Ltd. Acquires 3,000 Shares of Tenet Healthcare Corporation $THC

China Universal Asset Management Co. Ltd. grew its holdings in Tenet Healthcare Corporation (NYSE:THC) by 33.3% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,000 shares of the company’s stock after acquiring an additional 3,000 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in Tenet Healthcare were worth $2,436,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of THC. Crestwood Advisors Group LLC raised its holdings in Tenet Healthcare by 2.5% during the third quarter. Crestwood Advisors Group LLC now owns 2,606 shares of the company’s stock valued at $529,000 after buying an additional 64 shares in the last quarter. ProShare Advisors LLC raised its stake in shares of Tenet Healthcare by 1.7% in the 2nd quarter. ProShare Advisors LLC now owns 4,118 shares of the company’s stock valued at $725,000 after acquiring an additional 67 shares in the last quarter. Quadcap Wealth Management LLC lifted its holdings in Tenet Healthcare by 1.7% in the 2nd quarter. Quadcap Wealth Management LLC now owns 4,099 shares of the company’s stock worth $721,000 after purchasing an additional 69 shares during the last quarter. Andina Capital Management LLC grew its holdings in Tenet Healthcare by 2.1% during the third quarter. Andina Capital Management LLC now owns 3,360 shares of the company’s stock valued at $682,000 after purchasing an additional 69 shares during the last quarter. Finally, Assetmark Inc. raised its position in shares of Tenet Healthcare by 0.9% in the second quarter. Assetmark Inc. now owns 8,709 shares of the company’s stock valued at $1,533,000 after purchasing an additional 76 shares during the period. 95.44% of the stock is currently owned by institutional investors.

Tenet Healthcare Trading Down 1.8%

THC stock opened at $227.68 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. The firm has a market cap of $19.80 billion, a P/E ratio of 14.70, a P/E/G ratio of 1.14 and a beta of 1.44. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $235.77. The business’s 50 day moving average is $201.26 and its 200-day moving average is $196.69.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. The firm had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The business’s revenue was up 8.9% compared to the same quarter last year. During the same period in the prior year, the business posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Nadja West sold 2,178 shares of the firm’s stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the sale, the director directly owned 28,480 shares of the company’s stock, valued at $5,623,945.60. This trade represents a 7.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.81% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on THC. Truist Financial lifted their target price on shares of Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a report on Tuesday. Jefferies Financial Group boosted their price objective on Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. JPMorgan Chase & Co. raised their target price on Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Cantor Fitzgerald upped their price target on Tenet Healthcare from $190.00 to $245.00 and gave the stock an “overweight” rating in a report on Wednesday, October 29th. Finally, Raymond James Financial set a $245.00 target price on shares of Tenet Healthcare in a research report on Wednesday, October 29th. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $246.71.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.